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Abstract
The use of the copper (I)-assisted azide-alkyne cycloaddition (CuAAC, or “click” reaction) as a
method of β-hairpin stabilization was investigated at several different positions to determine the
impact on hairpin structure and function, including hydrogen bonded sites, non-hydrogen bonded
sites, and at the peptide termini. The role of the turn sequence in the peptide and the chain length
of the azied were also investigated. It was determined that the CuAAC reaction was a suitable
method for locking in β-hairpin structure in peptides possessing either the type I’ turn, VNGO and
the type II’ turn, VpGO. Moreover, all cyclic variants exhibited improved thermal stability and
resistance to proteolysis as compared to the non-cyclic peptides, regardless of the position in the
strand. Additionally, the function of the CuAAC cyclized peptides was not altered as exhibited by
similar binding affinities for ATP as the WKWK peptide. These studies provided a comprehensive
method for CuAAC cyclization of β-hairpin peptides, which could further be utilized in the
inhibition of protein-protein and protein-nucleic acid interactions.
Introduction
While small molecules are optimal for inhibition of enzymes, they have been less successful
at the inhibition of interactions between two biomolecules, such as protein-protein, protein-
DNA, and protein-RNA interactions. These interactions play a critical role in many disease
states, such as the p53-HDM2 interaction in cancer1, sirtuin1 and PGC1-α in diabetes2, and
CRP and PINK1 in atherosclerosis3 as examples of dysregulated protein-protein
interactions, and the binding of TAR RNA by the TAT protein interaction as an example of
a medicinally relevant protein-RNA interaction. For this reason, researchers have sought to
mimic the interface of PPIs and protein-nucleic acid interactions to disrupt the protein
contacts, thereby inhibiting or slowing the progression of disease. One approach to mimic
the interface is to excise the hotspot of a protein, the group of amino acids at the
intermolecular protein interface that contribute to most of the binding energy.4 However, it
is well known that isolation of a small portion of a protein often leads to an unfolded
peptide, and random coil peptides are susceptible to rapid enzymatic degradation. In
addition, the lack of structure often renders the peptide nonfunctional. To this end, there is a
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necessity to provide methods of stabilization of the structure as well as to minimize
proteolytic degradation and maintain functionality.
A significant amount of research has been accomplished in stabilizing peptide secondary
structural motifs. Several groups report the use of chemical methods that are high-yielding
to stabilize α-helices through intramolecular side-chain reactions.5 Moellering et al. utilized
ring closing metathesis (RCM) on the dnMAML1 to stabilize its α-helical structure and
prove its ability to inhibit the Notch signaling pathway.6 While Arora’s group employed
RCM to afford a hydrogen bond surrogate in the backbone of an α-helical portion of
HIF-1α to inhibit p300.7 Klaveness and Bong have used copper (I)-assisted azide-alkyne
cycloaddition (CuAAC or “click’ cyclization)8 to stabilize 3,10-helices9 and α-helices5b,
respectively. More recently CuAAC has been used as a method to replace disulfide linkages
in an antibiotic, Tachyplesin I, which retained biological activity.10 In addition, Celentano et
al. have performed studies with a TrpZip peptide to incorporate the 1,4-triazole linkage in
the non-hydrogen bonded site of a β-hairpin.11
A common method for β-hairpin stabilization is cyclization via amide bond formation
through the backbone or side chains.12 However, these approaches are labor intensive and
often low yielding. In cases where a library of cyclic peptides is warranted, as in Robinson’s
approach to disrupting protein-RNA and protein-protein interactions with cyclic β-
hairpins,13 an alternate method of cyclization would be advantageous.
Herein, we report a comprehensive study of the impact of “click” cyclization on β-hairpin
structure and function through variation of the position of triazole incorporation in the
hairpin, the relative positions of azide and alkyne in the N- and C-terminal strands of the
hairpin, the turn sequence, and the chainlength of the azido amino acid. We find that while
there are some variations in stability, click cyclization is a general method to stabilize and in
some cases enhance the structure of β-hairpins with the incorporation of a 1,4-triazole,
regardless of position in the peptide, turn, or chainlength. We chose to utilize mutants of a
well-studied β-hairpin peptide, WKWK (Fig 1), to gain insights not only for structural
advantages but also impacts on function as this peptide was found to bind ATP.14 This study
not only demonstrates the structural advantages of the CuAAC in β-hairpins but also the
preservation of function and enhanced protection to proteolysis. Thus, CuAAC cyclization15




A series of β-hairpin peptides were designed based on the WKWK peptide to determine the
effects of cyclizing via CuAAC on structure and function (Fig 1). The WKWK peptide was
chosen as it has been thoroughly characterized and has been shown to be well folded.
Additionally, it is known to bind purine bases, specifically ATP with a Kd of 170 µM (Fig
2).14 Thus, click cyclization of variants of this sequence will allow us to investigate the
impact on function as well as structure. The two unnatural amino acids used for the CuAAC
cyclization were azidolysine (Azk) and propargylglycine (Pra). Azidolysine is easily
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synthetically accessible and allows for flexibility in the cyclic hairpin. These residues were
incorporated cross-strand from each other, with Azk in the N-terminal strand and Pra in the
C-terminal strand, along the β-hairpin in the hydrogen bonded (HB) positions, non-hydrogen
bonded (NHB) positions, and terminal (Term) positions (Fig1, Table I) to investigate
positional effects of the click cyclization on β-hairpins. In the HB position, Azk and Pra
make two cross-strand hydrogen bonds which rigidify these positions. In the NHB positions,
the Azk and Pra residues do not form any hydrogen bonds, giving the sidechains more
flexibility. Additionally the positions of Azk and Pra were reversed, such that Pra was in the
N-terminal strand and Azk was in the C-terminal strand, to determine any changes in
structure. These peptides are denoted with the suffix “rev” (Table I). The effect of the turn
sequence was also investigated for all positions by replacing the type I’ VNGO turn in
WKWK with the type II’ VpGO turn. Each peptide was characterized by TOCSY and
NOESY 2D NMR and circular dichroism (CD). Peptide stability was evaluated via variable
temperature CD studies and protease degradation. Binding was assessed via fluorescence
quenching of the Trp residues for applicable peptides.
Structural Studies of the Clicked β-hairpins
Circular Dichroism and 2-D NMR Studies—Structural studies were performed on all
uncyclized (denoted by the suffix “U”) and cyclic peptides (denoted by the suffix “C”) via
circular dichroism (CD) and 2-D NMR techniques including TOCSY and NOESY, to assess
the influence of cyclization by CuAAC on structure. The β-sheet structure is characterized
by a global minimum between 210 nm and 215 nm with a corresponding maximum at 195
nm. A random coil peptide is expected to have a global minimum at 195 nm. 2-D TOCSY
and NOESY NMR spectra were acquired on all peptide variants. Downfield shifting of ≥ 0.1
ppm of the α-hydrogens (Hα) along the peptide backbone relative to unfolded values
indicates a β-sheet conformation. The NOESY spectra were used to determine proper
folding registry in the hairpin and additional interactions between residues.
Terminal Positions for Cyclization—The CD spectrum (Fig 3A) of Term-U and Term-
rev-U show a minimum at 212 nm and maximum at 195 nm, distinctive of a global β-hairpin
conformation. The cyclic counterparts, Term-C and Term-rev-C exhibit a more intense
minimum at the same wavelength suggesting an overall more structured hairpin. Additional
confirmation of proper structure is seen with the exciton coupling peak at 225 nm stemming
from diagonal Trp interactions which is also seen in the WKWK parent peptide.14 The NMR
data show that non-cyclic and cyclic Term and Term-rev do not display a distinct change in
Hα shifts (Fig 3B). The extent of splitting of the diastereotopic Hα’s of Gly correlates with
hairpin folding at the turn.15 Both non-cyclic and cyclic peptides of Term and Term-rev
have a glycine splitting value of 0.74 ppm, indicating no drastic change in hairpin folding.
This lack in difference is most likely due to the position of the CuAAC. There are several
aspects to note in comparing the Hα shifts of the non-cyclic and cyclic peptides. Azk, at
position -1 or 14, and Pra, at position 13 or -1, are more downfield shifted in the Term-C and
Term-rev-C, respectively, suggesting the ends are pulled closer together. Other terminal
positions are also stabilized as seen by the downfield shifts of Arg1Hα and Gln12Hα
compared to the parent WKWK. Interestingly there is a slight difference in the reversal of
the azide and alkyne (Term-rev) which is notable in the shift of Lys11Hα. In WKWK, the
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Lys11Hα is upfield shifted stemming from ring current effects from the cross-strand Trp2.
This same trend is seen in Term-U, however upon cyclization Lys11Hα is upfield shifted
whereas the the reverse trend is seen in Term-rev. This suggests that there are slight nuances
in choosing which strand the CuAAC functional groups are placed. Residues surrounding
the CuAAC functional groups can certainly impact the structure as is supported by the NOE
data (Fig 4). One of the Lys11Hγ of Term-C has a strong NOE with the triazole proton
indicating that the presence of the triazole aromatic ring allows Lys11 to have another
interaction. This conformation could be inaccessible in the Term-rev-C peptide, thus the
downfield shifting is seen as in WKWK.
There are strong NOEs between the Lys4Hα and Trp9Hα, and Lys11Hα and Trp2Hα
confirming the correct registry for the β-hairpin. Additional NOE contacts are seen between
the side chains of Lys4 and Lys11 and their cross-strand Trp residues, Trp2 and Trp9.
However, there is not a significant increase in the contacts between strands upon CuAAC
hairpin cyclization. Similar trends were observed in the peptides with a type II’ turn
sequence, Term-pG (SI Fig S3 & S4). Overall cyclization at the terminal position does not
appear to enhance β-hairpin formation dramatically. In addition, there does not appear to be
a marked difference in decreasing the number of methylene spacers in the azide residue,
from 4 to 3 to 2 to 1, making the loop smaller, (SI Fig S5).
Non-hydrogen bonded position for cyclization—Replacement of the Trp2 and
Lys11 cross-strand pair in a non-hydrogen bonded position deters β-hairpin folding since
one of the stabilizing Trp-Lys pairs seen in WKWK is removed. This is also apparent in the
CD of NHB-U (Fig 5A). The CD spectrum of NHB-U has two minima, one at 205 nm and
the other at 215 nm with a maximum at 195 nm suggesting a partially folded structure.
NHB-rev-U was not fully soluble and formed a gel-like substance under the same conditions
(50 mM KD2PO4, pH 7, 20°C) and required a much lower pH to attain solubility. Thus a CD
spectrum was not acquired. This again supports the fact that position of the CuAAC
functional groups is important. NHB-C and NHB-rev-C both show more hairpin
conformation as seen by the sharp decrease in ellipticity at 215 nm. There is a slight
shoulder at 205 nm suggesting some population of an unknown structure as seen in NHB-U.
The difference in Hα shifts (Fig 5B) agrees with the CD data. Most of the residues in the
cyclic peptides display greater downfield shifting than that of the non-cyclic peptides. The
glycine splitting values are also far greater for the cyclic peptides at 0.72 ppm and 0.71 ppm
relative to 0.63 ppm and 0.55 ppm for NHB and NHB-rev. It appears that covalent linkage at
the non-hydrogen bonded site restores stability provided by noncovalent interactions in
WKWK. Additionally for NHB-rev, cyclizing restored solubility. The NOESY spectra (Fig
6) better display the structural details of this peptide set. For NHB-U a strong NOE is
observed between Lys4Hα and Trp9Hα confirming correct registry, however there is no
NOE seen between Azk2 and Pra11. There are additional contacts between the side chains
of Lys4 and Trp9. The NOE between Trp9H4 with Val3Hα implies that Trp9 is sandwiched
Azk2 and Lys4. NHB-C is also in the correct registry thus showing that click cyclization in
the non-hydrogen bonded position does not alter the type of hairpin formed. The
sandwiching of Trp9 is far more pronounced in NHB-C as evidenced by NOEs present
between Trp9H4 and the methylenes of Azk2. NHB-rev-U does not have any cross-strand
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backbone NOEs, suggesting that a β-hairpin is not formed. Instead there is a strong NOE
between Azk11Hα and Trp9Hα. Even upon click cyclization no cross-strand NOEs are seen
to confirm the correct registry (Fig 6C&D). However, there are strong NOEs observed
between Pra2Hα and Lys4Hα as well as between Trp9Hα and Azk11Hα. Structurally the
observable NOEs imply a cradling of the hairpin where the terminal ends are sandwiched on
top of the residues closer to the turn. NOEs between Trp9 and Lys4 as well as the triazole
proton support this structure. Click cyclization at the NHB position of the peptide with the
type II’ turn, NHB-pG, displayed similar results in the NOEs (SI Fig S7). However, the
difference between the CD and Hα shifts of the non-cyclic and cyclic NHB-pG were less
pronounced than the type I’ turn peptides (SI Fig S6). From these data we conclude that
click cyclizing at the non-hydrogen bonded position does indeed stabilize hairpin structure,
but with possible distortion.
Hydrogen bonded position for cyclization—The CD spectra of the HB-U and HB-
rev-U peptides (Fig 7A) have a broad minimum spanning from 200 nm to 218 nm. Click
cyclization for both HB and HB-rev stabilizes a β-hairpin structure as evidenced by a sharp
minimum at 215 nm. Exciton coupling at 225 nm from the diagonal Trp2 and Trp9
interaction also confirms the formation of a β-hairpin. The difference in Hα shifts relative to
random coil values agree with the CD as nearly all the Hα’s in the cyclic peptides exhibit
more downfield shifting than the non-cyclic peptides. Additionally the glycine splitting
values for HB-U and HB-rev-U increase from 0.48 ppm and 0.59 ppm to 0.66 ppm to 0.69
ppm, respectively, upon triazole formation. This implies that the peptides become more
well-folded. Again there are some nuances upon flipping of the click functional groups
apparent in Lys4Hα and Lys11Hα (Fig 7B). In the parent WKWK peptide the Lys4Hα is
seen to be upfield shifted relative to random coil while Lys11Hα is downfield shifted. HB-U
and HB-C both share the same trend as WKWK (Fig 7); however, in HB-rev the trend is
reversed where Lys4Hα is downfield shifted and Lys11Hα is upfield shifted. NOEs (Fig 8)
provide additional insight into the structural impacts of click cyclization. In both cases
NOEs are seen between cross-strand Trp and Lys residues to indicate proper strand registry.
HB-rev has several NOEs between crosstrand Trp and Lys pairs as well as additional
contacts between Trp and other protons. There is a significant increase in the number of
NOEs seen between side-chains upon click cyclization. As with the Term and NHB
positions, substitution of the turn residues to the type II’ turn, dPro-Gly, sequence in the HB
peptide lead to similar results (SI Fig S8 & S9).
Thermal stability of click cyclized β-hairpins
The thermal stability of the peptides was assessed by thermal denaturation monitored by
circular dichroism. No direct measurement of melting temperature could be made as no
standard S-curve was observed. Nonetheless, in all positions the cyclic peptide exhibited
increased thermal stability compared to the non-cyclic peptides (Fig S1) as expected. For all
the type II’ turn peptides, an increase in thermal stability of the cyclic peptides was also
observed (SI Fig S2). From these results it can be confirmed that CuAAC cyclization of
peptides affords stability to β-hairpins regardless of the position of the reaction.
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Proteolytic stability of click cyclized β-hairpins
The triazole moiety is known to impart protease resistance as well as is cyclization of a
peptide.18 Thus we sought to test the proteolytic stability of the non-cyclic and cyclic
peptides by incubation with Pronase E, which is a mixture of non-specific endo- and exo-
serine proteases. The type II’ turn sequences were chosen for experimental purposes as it is
known that the dPro-Gly turn sequence enhances resistance to protease degradation, thus
allowing for measurable half-lives under the conditions.18 Table 2 summarizes the half-life
of each peptide under the conditions described. The β-hairpin peptides were compared to a
control unstructured peptide, Scramble, which consisted of a random order of the residues in
Term-pG. The half-life of Scramble was found to be 3 minutes, while the non-cyclic
peptides HB-pG-U, NHB-pG-U, and Term-pG-U had half-lives of 15, 20, and 60 minutes.
The Term-pG-U was found to be the least susceptible to degradation compared to the other
non-cyclic peptides, most likely due to being the most well-folded.18 The CuAAC
cyclization improved resistance to proteolytic degradation on all accounts, where HB-pG-C
had a half-life 18-fold greater than HB-pG-U, NHB-pG-C showed no observable
degradation, and Term-pG-C had a half-life at least 5-fold greater than Term-pG-U and 100-
fold greater than Scramble. As the NHB-pG-C peptide did not degrade under the Pronase E
conditions, its robustness was also tested using the protease Trypsin which cleaves after the
basic amino acids, Arg and Lys. Under trypsin degradation, NHB-pG-C had a half-life of 40
mins which was 4 times greater than the non-cyclic peptide (SI Fig S17 & S18).
Additionally, the degradation products were analyzed by mass spectrometry which showed
that only the termini were cleaved leaving an intact clicked cycle as the only product.
Together these data demonstrate that click cyclization significantly increases protease
resistance.
Assessing the ability of clicked β-hairpins to recognize ATP
WKWK binds ATP with a binding constant of 170 µM.14 The efficacy of the CuAAC
peptides to recognize ATP was also assessed for Term and HB peptides as they still contain
the necessary Trp-Lys cross-strand pairs for recognition. Term-C and Term-rev-C were
determined to have binding constants of 109 uM and 141 uM respectively (Table 3, SI Fig
S19). These values do not differ significantly from WKWK. HB-C (Kd = 152 uM) and HB-
rev-C (Kd = 267 uM) also bind ATP with comparable affinity. Thus, clicking in these
positions has not altered the function of these peptides, providing further support that the
overall β-hairpin structure is maintained.
Conclusions
We determined that placing residues compatible for the CuAAC at the terminal ends of a
well-folded β-hairpin maintains structure and affords resistance to proteolytic degradation
and increased thermal stability. In addition, the function of the peptide is not eliminated and
remains comparable to the parent peptide, WKWK. Decreasing the loop size in the cyclic
peptide by shortening the azide chain for the terminal position does not impact folding
significantly. However, work by Celentano et al. have shown there to be a difference in
linker length when the CuAAC participating residues are in the NHB positions.11
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Cyclizing via the formation of a 1,4-triazole functional group in the non-hyrogen bonded
positions improves β-hairpin structure, as evidenced by CD and NMR data. Additionally it
can improve solubility as is seen with NHB-rev. In this specific case, Trp9 is sandwiched
between the triazole moiety and Lys4; however, this may not be standard to every β-hairpin
sequence. The NOESY data clearly indicate that there are more established contacts between
the two strands upon cyclization.
Moving the 1,4-triazole to the hydrogen bonded position is most effective in stabilizing the
β hairpin structure. This position has intermediate protease stability (SI Fig S11) most likely
since there are more residues outside the macrocycle than the other peptides. As in the
terminal position, no disruption in binding affinity to ATP is observed.
In summary, the use of the CuAAC reaction afforded an approach to synthesize cyclic β-
hairpins in a robust, quick, and high yielding manner that display significant protease
resistance while maintaining structure and function. This is a promising approach for
producing cyclic β-hairpin peptides for inhibition of protein-protein and protein-nucleic acid
interactions.
Experimental
Synthesis and Purification of Peptides
Peptides were synthesized by automated solid-phase peptide synthesis on a Thuramed
TetrasUI peptide synthesizer using Fmoc-protected amino acids on CLEAR-amide resin
purchased from Peptides International. All natural Fmoc-[N]-protected amino acids were
purchased from Advanced Chem Tech. Fmoc-[N]-L-propargyl glycine was purchased from
Anaspec and Fmoc-[N]-azidolysine was synthesized from commercially available Fmoc-
[N]-Lys-OH from NovaBiochem. Activation of amino acids was performed with HBTU and
HOBt in the presence of DIPEA in DMF and NMP. Peptide deprotection was carried out in
2% DBU (1,8-diazobicyclo[5.4.0]undec-7-ene) and 2% piperidine in DMF for 2 cycles of
approximately 15 min each. Each coupling step was performed twice for approximately 30
min. All peptides were acetylated at the N-terminus with 5% acetic anhydride and 6% 2,6-
lutidene in DMF for 35 min. Cleavage of the peptide from the resin was performed in
95:2.5:2.5 trifluoroacetic acid (TFA): triisopropylsilane (TIPS): water for 3 h. For peptides
containing cysteine 94:2.5:2.5:1 trifluoroacetic acid (TFA): ethanedithiol (EDT): TIPS:
water was used. TFA was evaporated and cleavage products were precipitated with cold
ether. The peptide was extracted into water and lyophilized. It was then purified by reverse-
phase HPLC using an Atlantis C-18 semi-preparative column and a gradient of 0 to 100%B
over 45 min or 60 min, where solvent A was 95:5 water:acetonitrile with 0.1% TFA and
solvent B was 95:5 acetonitrile: water with 0.1% TFA. After purification, the peptide was
lyophilized to a powder and identified with ESI-TOF mass spectroscopy.
Synthesis of α-N-Fmoc-ε-azido-L-Lysine.20
Fmoc-Lysine-OH (2.7 mmol, 1 eq), potassium carbonate (5.5 mmol, 2 eq), and copper (II)
sulfate pentahydrate (0.028 mmol, 1 mol %) were stirred in MeOH (15 mL) for 10 mins.
Imidazole-1-sulfonyl azide·HCl (3.3 mmol, 1.2 eq) was then added. [Saftey precaution:
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imidazole-1-sulfonyl azide is potentially explosive. Aliquots of less than one gram were
stored at 4°C.] This was allowed to react overnight. The reaction mixture was diluted with
water (2.5 mL) and the MeOH was removed via rotary evaporation. The reaction was
diluted with more water (30 mL) and acidified with HCl (ca. 1 mL). Crude product was
extracted into ethyl acetate (3 × 25 mL). The organic layers were combined and dried over
MgSO4. Fmoc-Azidolysine-OH was purified by silica gel column chromatography (3–10%
MeOH in CH2Cl2) to give the desired product as a white solid (80% yield). 1H NMR (400
MHz, CD3OD): δ 7.69 (d, J = 7.6, 2H), δ 7.60 (t, J = 8.0, 2H), δ7.31 (t, J = 7.2, 2H), δ 7.24
(t, J = 7.2, 2H), δ 4.30 (d, J = 6.8, 2H), δ 4.19 (m, 1H), δ 4.13 (t,J = 6.8, 1H), δ 3.17 (m,
2H), δ 1.90-1.35 (m, 6H)
Synthesis of tris-tri(methylazolyl)amine ligand.21
Methylbromoacetate (3.44 mmol, 1 eq) was dissolved in acetone (1.5 mL) and brought to
0°C. Sodium azide (3.56 mmol, 1.03 eq) was dissolved in water (1.5 mL) and slowly added
dropwise to the reaction mixture. The mixture was then allowed to warm to room
temperature and then heated to 65°C and stirred overnight. Azidomethylacetate was
extracted using CH2Cl2 (3 × 10 mL). The organic layers were combined and dried over
Na2SO4. The organics were then rotary evaporated to give azidomethylacetate.
Tripropargylamine (0.44 mmol, 1eq) was dissolved in CH3CN (1 mL) and cooled to −5°C.
To this was added azidomethylacetate (1.72 mmol, 3.9 eq) in CH3CN (1 mL) slowly over 5
mins. 2,6-lutidine (0.44 mmol, 1 eq) and Cu(MeCN)4PF6 (0.0088 mmol, 2 mol %) was
added. The mixture was brought to room temperature then heated to 65°C and allowed to
stir for 3 days under a N2 atmosphere. The CH3CN was rotary evaporated to dryness. The
product was purified by silica gel column chromatography (3 % MeOH in CH2Cl2) to give
the desired product as an off white solid (82% yield). 1H NMR (400 MHz, CDCl3): δ 7.84
(s, 1H), δ 5.18 (s, 2H), δ 3.79 (s, 2H), δ 3.78 (s, 3H). High-resolution ESI-MS: m/z
calculated for C18H24N10O6 (M + Cs+), 609.0935; observed 609.0920.
General Procedure for the Cyclization of Peptides using CuAAC
To a solution of peptide (1 mM) in 10 mM phosphate, pH 8.0 buffer was added a premixed
solution of tris-tri(methylazolyl)amine ligand (2.7 eq) and [Cu(CH3CN)4][PF6] (1.8 eq) in
acetonitrile. Sodium ascorbate (2.1 eq) dissolved in minimal buffer was added to the
reaction. This solution was stirred overnight in the dark. The reaction mixture was quenched
with %A HPLC solvent and lyophilized to a powder. The reaction was further desalted
followed by HPLC purification. The yields were quantitative.
NMR Spectroscopy
NMR samples were made to a concentration of at least 1mM in D2O buffered to pD 7.0
(uncorrected) with 50 mM KPO4D2, 0.5mM DSS. Samples were analyzed on a Varian Inova
600-MHz instrument. One dimensional spectra were collected using 32K data points and
between 8 and 36 scans using 1.5 s presaturation. Two dimensional total correlation
spectroscopy (TOCSY) and nuclear Overhauser spectroscopy (NOESY) experiments were
carried out using the pulse sequences from the Chempack software. Scans in the TOCSY
experiment were taken from 16 to 32 in the first dimension and from 64 to 128 in the second
Park and Waters Page 8






















dimension. Scans in the NOESY experiments were taken from 32 to 64 in the first
dimension and from 128 to 512 in the second dimension with mixing times of 200–500 ms.
All spectra were analyzed using standard window functions (sinbell and Gaussian with
shifting). Presaturation was used to suppress the water resonance. Assignments were made
by using standard methods as described by Wüthrich.20 All experiments were run at
298.15K.
Circular Dichroism (CD) spectroscopy
CD spectroscopy was performed on an Applied Photophysics Chirscan Plus. Spectra were
collected from 260 to 185 nm at 0.5 nm intervals at 25°C. Melting temperature spectra were
collected along the same wavelengths from 25°C to 90°C.
Peptidase Concentration
Enzymes were purchase from Sigma-Aldrich, pronase E from Streptomyces griseus (EC
3.4.24.31) as a solid and trypsin from bovine pancrease as a lyophilized powder containing
lactose. Pronase E and trypsin were brought up in 10mM sodium phosphate, 140mM NaCl
buffer, pH 7.6 to 0.3 mg/mL.
Peptidase Degradation Reactions
The procedure for peptidase studies was adapted from Seebach et al.21 For each reaction,
0.25 mM peptide in the phosphate buffer (140mM Na+/K+Cl− buffer pH 7.6) was reacted
with the appropriate concentration of enzyme at 37°C. A 75 µL aliquot was removed after 0,
5, 10, 15, 30, 45, 60, 90, 120, 190, 270, 360, 480, 600, 720, 840, 1100, 1260, 1440, 1680
min time points, quenched with 10 µL glacial acetic acid and 15 µL of buffer, brining the
final volume to 100 µL. A 10 µL aliquot was injected on a Waters Alliance 2695 with an
Atlantis C-18 column using a 0–40%B in 45 mins gradient. The acetic acid peak was used as
an internal control to account for differences in the injection volumes by the autosampler.
The parent peak and the acetic acid peak were integrated using the accompanying software.
To determine the fraction of full-length peptides remaining at each of the time points, the
peak area for the full-length peptides was divided by the peak are at the zero time point.
Fluorescence Quenching Experiments with ATP
Peptide samples were prepared by dissolving purified peptide in 10 mM acetate buffer, pH
5.0. The concentrations of the peptide was determined in 5M guanidine hydrochloride using
the absorbance of the Trp residues at 280 nm (ε = 5690 M−1 cm−1). An ATP stock solution
was prepared by dissolving in 10 mM acetate buffer, pH 5.0, and the concentration was
determined using the absorbance at 260 nm (ε = 15400 M−1 cm−1). ATP concentrations
were prepared via serial dilutions. Samples were prepared where the peptide host
concentrations were held constant with increasing concentrations of guest. Fluorescence
scans were obtained at 25°C using an excitation wavelength of 297 nm for Trp. Emission
was monitored between at 348 nm. The emission intensities of Trp at 348 nm as a function
of nucleotide concentration were fit to this binding equation in
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Kaleidagraph, where I is the observed fluorescence intensity, I0 is the initial intensity, I8 is
the fluorescence intensity at binding saturation, [L] is the concentration of ATP added, and
Kd is the dissociation constant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Peptides investigated for CuAAC hairpin cyclization. The functional amino acids for
CuAAC, A and B, are varied along terminal (Term, red), non-hydrogen bonded (NHB,
blue), and hydrogen bonded (HB, green) positions. The turn residues (orange) can be one of
two sequences, VNGO (shown) or VpGO, where p = dPro. Dashed lines represent hydrogen
bonds.
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Molecular dynamics simulation of WKWK (yellow) with the Trp shown in stick form bound
to ATP (green).16 The peptide structure is based on an NMR structure.
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(A) Circular dichroism spectra for terminal position peptides. 50 µM peptide in 10 mM
sodium phosphate buffer, pH 7.4. (B) Chemical shift differences of Hα for terminal position
peptides. Values for Gly* are glycine splitting values. TOCSY data were acquired with
peptide concentrations at 1 mM in 50 mM KD2PO4, pH 7 buffer at 20 °C.
Park and Waters Page 14























Unambiguous NOEs seen for A) Term-U, B) Term-C, C) Term-rev-U, D) Term-rev-C
Shown are cross strand interactions (blue) confirming registry, triazole interactions (green),
and residue interactions (red). NOESY spectra were acquired with peptide concentration
around 1 mM in 50 mM KD2PO4, pH 7 buffer at 20 °C.
Park and Waters Page 15























(A) Circular dichroism spectra for non-hydrogen bonded position peptides. 50 µM peptide in
10 mM sodium phosphate buffer, pH 7.4. (B) Chemical shift differences of Hα for non-
hydrogen bonded position peptides. Values for Gly* are glycine splitting values. TOCSY
data were acquired with peptide concentrations at 1 mM in 50 mM KD2PO4, pH 7 buffer at
20 °C with the exception of NHB-rev-U which was acquired in a 50 mM d-acetate buffer,
pH 4.0.
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Unambiguous NOEs seen for A) NHB-U, B) NHB-C, C) NHB-rev-U, D) NHB-rev-C
Shown are cross strand interactions (blue) confirming registry, triazole interactions (green),
and residue interactions (red). NOESY spectra were acquired with peptide concentration
around 1 mM in 50 mM KD2PO4, pH 7 buffer at 20 °C with the exception of NHB-rev-U
which was acquired in a 50 mM d-acetate buffer, pH 4.0.
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(A) Circular dichroism spectra for hydrogen bonded position peptides. 50 µM peptide in 10
mM sodium phosphate buffer, pH 7.4. (B) Chemical shift differences of Hα for hydrogen
bonded position peptides. Values for Gly* are glycine splitting values. TOCSY data were
acquired with peptide concentrations at 1 mM in 50 mM KD2PO4, pH 7 buffer at 20 °C.
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Unambiguous NOEs seen for A) HB-U, B) HB-C, C) HB-rev-U, D) HB-rev-C Shown are
cross strand interactions (blue) confirming registry, triazole interactions (green), and residue
interactions (red). NOESY spectra were acquired with peptide concentration around 1 mM
in 50 mM KD2PO4, pH 7 buffer at 20 °C.
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Table I












Residues involved in turn sequence are underlined. Residues involved in potential ATP recognition are in bold. Prefixes of “U” and “C” denote
linear unclicked and cyclic clicked peptides. p = dPro.
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Table 2
Half-lives of type II’ turn peptides treated with Pronase E*
t1/2 (min)
Peptide U C
Scramble** 3 (± 5) --
HB-pG 15 (± 5) 280 (± 5)
NHB-pG 20 (± 5) No observable degradation***
Term-pG 60 (± 5) > 300
*




Over a 48 hour time period
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Table 3
Binding Constants of Peptides for ATP
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